Literature DB >> 18675938

Residual cognitive effects of uncomplicated idiopathic and cryptogenic epilepsy.

Anne T Berg1, John T Langfitt, Francine M Testa, Susan R Levy, Francis DiMario, Michael Westerveld, Joseph Kulas.   

Abstract

We assessed residual cognitive deficits in young people with idiopathic and cryptogenic epilepsy. In the setting of an ongoing prospective study, we invited participants initially diagnosed and enrolled in the cohort 8-9 years earlier to undergo standardized neuropsychological assessment. Sibling controls were invited when available. We analyzed 143 pairs in which cases had idiopathic or cryptogenic epilepsy and both case and control had normal intelligence. Compared with that for siblings, the Full Scale IQ for cases was 3.3 points lower (P=0.01) mainly due to slower processing speed, which was 5.6 points lower (P=0.0004). Word reading (P=0.04) and spelling (P=0.01), but not other scores, were also lower in cases. Remission status and drug use did not influence findings. In young people of normal intelligence with idiopathic or cryptogenic childhood-onset epilepsy, substantial residual effects of epilepsy appear to be confined largely to slower processing speed.

Entities:  

Mesh:

Year:  2008        PMID: 18675938     DOI: 10.1016/j.yebeh.2008.07.007

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  19 in total

1.  Cognition, academic achievement, language, and psychopathology in pediatric chronic epilepsy: Short-term outcomes.

Authors:  Jana E Jones; Prabha Siddarth; Suresh Gurbani; W Donald Shields; Rochelle Caplan
Journal:  Epilepsy Behav       Date:  2010-05-14       Impact factor: 2.937

2.  Behavior problems in children at time of first recognized seizure and changes over the following 3 years.

Authors:  J K Austin; S M Perkins; C S Johnson; P S Fastenau; A W Byars; T J deGrauw; D W Dunn
Journal:  Epilepsy Behav       Date:  2011-07-03       Impact factor: 2.937

3.  Cognitive slowing and its underlying neurobiology in temporal lobe epilepsy.

Authors:  Gyujoon Hwang; Kevin Dabbs; Lisa Conant; Veena A Nair; Jed Mathis; Dace N Almane; Andrew Nencka; Rasmus Birn; Colin Humphries; Manoj Raghavan; Edgar A DeYoe; Aaron F Struck; Rama Maganti; Jeffrey R Binder; Elizabeth Meyerand; Vivek Prabhakaran; Bruce Hermann
Journal:  Cortex       Date:  2019-03-05       Impact factor: 4.027

4.  Regional brain volumes and cognition in childhood epilepsy: does size really matter?

Authors:  Frank A Zelko; Heath R Pardoe; Sarah R Blackstone; Graeme D Jackson; Anne T Berg
Journal:  Epilepsy Res       Date:  2014-02-19       Impact factor: 3.045

5.  Psychiatric and medical comorbidity and quality of life outcomes in childhood-onset epilepsy.

Authors:  Christine B Baca; Barbara G Vickrey; Rochelle Caplan; Stefanie D Vassar; Anne T Berg
Journal:  Pediatrics       Date:  2011-11-28       Impact factor: 7.124

6.  Psychiatric and neurodevelopmental disorders in childhood-onset epilepsy.

Authors:  Anne T Berg; Rochelle Caplan; Dale C Hesdorffer
Journal:  Epilepsy Behav       Date:  2011-02-18       Impact factor: 2.937

7.  Deficits in oculomotor performance in pediatric epilepsy.

Authors:  Miya R Asato; Natalie Nawarawong; Bruce Hermann; Patricia Crumrine; Beatriz Luna
Journal:  Epilepsia       Date:  2010-11-18       Impact factor: 5.864

8.  Adaptive behavior and later school achievement in children with early-onset epilepsy.

Authors:  Anne T Berg; Rochelle Caplan; Christine B Baca; Barbara G Vickrey
Journal:  Dev Med Child Neurol       Date:  2013-03-27       Impact factor: 5.449

Review 9.  Cognitive and neurodevelopmental comorbidities in paediatric epilepsy.

Authors:  Katherine C Nickels; Michael J Zaccariello; Lorie D Hamiwka; Elaine C Wirrell
Journal:  Nat Rev Neurol       Date:  2016-07-22       Impact factor: 42.937

10.  The neuropsychological and academic substrate of new/recent-onset epilepsies.

Authors:  Daren C Jackson; Kevin Dabbs; Natalie M Walker; Jana E Jones; David A Hsu; Carl E Stafstrom; Michael Seidenberg; Bruce P Hermann
Journal:  J Pediatr       Date:  2012-12-05       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.